Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Accumulated Depreciation & Amortization (2016 - 2026)

Bio-Techne has reported Accumulated Depreciation & Amortization over the past 16 years, most recently at $293.1 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 8.43% year-over-year to $293.1 million; the TTM value through Dec 2025 reached $293.1 million, up 8.43%, while the annual FY2025 figure was $286.1 million, 11.53% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $293.1 million at Bio-Techne, up from $289.0 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $293.1 million in Q4 2025 and troughed at $186.9 million in Q1 2021.
  • A 5-year average of $238.6 million and a median of $237.3 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 12.36% in 2021 and later rose 8.43% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $201.1 million in 2021, then increased by 11.07% to $223.3 million in 2022, then increased by 9.79% to $245.2 million in 2023, then increased by 10.24% to $270.3 million in 2024, then grew by 8.43% to $293.1 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for TECH at $293.1 million in Q4 2025, $289.0 million in Q3 2025, and $286.1 million in Q2 2025.